HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joost J Oudejans Selected Research

human AR protein

12/2012Immunophenotyping of male breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joost J Oudejans Research Topics

Disease

13Neoplasms (Cancer)
01/2014 - 01/2002
8B-Cell Lymphoma (Lymphoma, B Cell)
01/2008 - 03/2002
7Lymphoma (Lymphomas)
04/2010 - 01/2002
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2010 - 03/2002
5Male Breast Neoplasms (Male Breast Cancer)
12/2012 - 03/2012
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2006 - 01/2005
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2015 - 06/2002
2Breast Neoplasms (Breast Cancer)
01/2014 - 08/2012
2Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2010 - 01/2002
2Melanoma (Melanoma, Malignant)
08/2008 - 09/2005
2Nasopharyngeal Carcinoma
07/2005 - 12/2002
2Hodgkin Disease (Hodgkin's Disease)
07/2002 - 01/2002
1Noninfiltrating Intraductal Carcinoma (DCIS)
05/2014
1Carcinoma (Carcinomatosis)
05/2014
1Hypoxia (Hypoxemia)
10/2012
1Carcinogenesis
08/2012
1Aplastic Anemia (Anemia, Hypoplastic)
02/2008
1Necrosis
08/2006
1Neoplasm Metastasis (Metastasis)
07/2005
1Genomic Instability
01/2005
1Fanconi Anemia (Fanconi's Anemia)
01/2005
1Hypersensitivity (Allergy)
01/2005
1Burkitt Lymphoma (Burkitt's Lymphoma)
03/2002
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2002

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
12/2012 - 03/2002
5CaspasesIBA
07/2005 - 03/2002
4Granzymes (Granzyme)IBA
08/2008 - 01/2002
3Caspase 9IBA
01/2008 - 04/2005
3Caspase 3 (Caspase-3)IBA
07/2005 - 03/2002
2Phenobarbital (Luminal)FDA Link
05/2014 - 03/2012
2Progesterone Receptors (Progesterone Receptor)IBA
12/2012 - 03/2012
2Biomarkers (Surrogate Marker)IBA
12/2012 - 08/2012
2ErbB Receptors (EGF Receptor)IBA
12/2012 - 03/2012
2Protease Inhibitors (Protease Inhibitor)IBA
09/2005 - 01/2002
2AntibodiesIBA
07/2005 - 03/2002
2Caspase 8 (Caspase-8)IBA
04/2005 - 04/2005
1Bortezomib (Velcade)FDA Link
09/2015
1human AR proteinIBA
12/2012
1Keratins (Keratin)IBA
12/2012
1Cyclin D1IBA
12/2012
1Carbonic Anhydrase IXIBA
10/2012
1TNF Receptor-Associated Factor 4IBA
08/2012
1Estrogen ReceptorsIBA
03/2012
1Rituximab (Mabthera)FDA Link
04/2010
1Apoptosis Regulatory ProteinsIBA
04/2010
1Histocompatibility Antigens Class IIIBA
08/2008
1Histocompatibility Antigens Class IIBA
08/2008
1thymoglobulinFDA Link
02/2008
1X-Linked Inhibitor of Apoptosis ProteinIBA
01/2008
1Pharmaceutical PreparationsIBA
11/2006
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
11/2006
1Aurora Kinase BIBA
11/2006
1Inhibitor of Apoptosis ProteinsIBA
09/2006
1Death Domain ReceptorsIBA
08/2006
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
08/2006
1TNF-Related Apoptosis-Inducing LigandIBA
08/2006
1ParaffinIBA
09/2005
1AntigensIBA
07/2005
1Etoposide (VP 16)FDA LinkGeneric
04/2005
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
04/2005
1Cisplatin (Platino)FDA LinkGeneric
01/2005
1Fanconi Anemia Complementation Group D2 ProteinIBA
01/2005
1PlatinumIBA
01/2005
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
03/2002
1Effector CaspasesIBA
03/2002
1Serine Proteases (Serine Protease)IBA
01/2002
1Monoclonal AntibodiesIBA
01/2002

Therapy/Procedure

10Drug Therapy (Chemotherapy)
04/2010 - 07/2002
8Therapeutics
01/2014 - 03/2002
2Ligation
08/2012 - 07/2012
1Molecular Targeted Therapy
04/2010
1Combination Drug Therapy (Combination Chemotherapy)
09/2006
1Neoadjuvant Therapy
09/2006
1Immunotherapy
09/2005
1Radiotherapy
07/2005